Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial

Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new history entry Revision: v3.4.2 was added and Revision: v3.4.1 removed; there are no changes to study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:21:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added revision entry v3.4.1 to the record history and removed v3.4.0. This reflects an internal version update to the page rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-02-04T23:01:55.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    UI enhancements to the study record history include a glossary display and color-coded change highlights (green for additions, red for deletions) with explanatory labels. The revision banner now shows Revision: v3.4.0, replacing the previous v3.3.4.
    Difference
    1%
    Check dated 2026-01-28T21:29:12.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New revision entry v3.3.4 added and previous revision v3.3.3 removed from the history log. This reflects backend versioning changes and does not modify the study data or page functionality.
    Difference
    0.1%
    Check dated 2026-01-14T04:17:38.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Record History now includes a new Study Status entry on 2025-12-30. The total number of Study Record Versions is updated to 11 on 2025-12-23, and a deletion occurred on 2025-10-01.
    Difference
    0.4%
    Check dated 2025-12-30T23:52:59.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Footer area now displays Revision: v3.3.3 and no longer shows HHS Vulnerability Disclosure or Revision: v3.3.2. This is a minor site maintenance change and does not affect the study record content.
    Difference
    0.2%
    Check dated 2025-12-23T22:37:27.000Z thumbnail image

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.